Ascentis Independent Advisors

Position in SGMOQ — Sangamo Therapeutics, Inc

CIK 1845003 DALLAS, TX

Position in SGMOQ

as of Mar 31, 2026 · filed Apr 28, 2026 Compact

Position Value

$45,125

-$121,171 QoQ

Shares Held

180,500

-54.4% QoQ

Ownership

0.044%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

18 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Ascentis Independent Advisors holds $30,103 across 1 Biotechnology name.

#	Ticker	Company	Shares	Value (USD)	Open
1	ALNY	Alnylam Pharmaceuticals, Inc.	100	$30,103

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$45,125	180,500	-54.4%	Shares	Sole	2026-04-28
2025-12-31	$166,296	395,943	-5.5%	Shares	Sole	2026-01-29
2025-09-30	$280,691	418,943	+6.9%	Shares	Sole	2025-10-21
2025-06-30	$211,649	391,943	+5.4%	Shares	Sole	2025-07-14
2025-03-31	$245,482	371,943	+14.2%	Shares	Sole	2025-04-23
2024-12-31	$332,197	325,684	+22.2%	Shares	Sole	2025-01-24
2024-09-30	$231,841	266,484	+35.2%	Shares	Sole	2024-10-25
2024-06-30	$70,961	197,116	-2.0%	Shares	Sole	2024-07-29
2023-12-31	$108,661	201,225	+21.0%	Shares	Sole	2024-02-02
2023-09-30	$99,759	166,265	+22.5%	Shares	Sole	2023-10-20
2023-06-30	$176,494	135,765	0.0%	Shares	Sole	2023-07-19
2023-03-31	$238,946	135,765	-12.0%	Shares	Sole	2023-06-01
2022-03-31	$896,831	154,360	+7.4%	Shares	Sole	2022-05-18
2021-12-31	$1,078,260	143,768	+12.7%	Shares	Sole	2022-02-11
2021-09-30	$1,149,360	127,565	+0.2%	Shares	Sole	2021-11-15
2021-06-30	$1,523,876	127,308	+0.6%	Shares	Sole	2021-08-12
2021-03-31	$1,586,398	126,608	+2.3%	Shares	Sole	2021-05-13
2020-12-31	$1,932,783	123,817	—	Shares	Sole	2021-02-08
No filing history on record for this holder in this stock.